Medicamen Statements
ME
Medicamen Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
938.22
100
485.79
49.9
452.43
50.1
—
0
164.04
17.7
381.78
41.7
70.646
8.4
-25.335
-4
13.967
1.2
59.278
5.6
18.575
1.3
41.577
4.5
3.21
12.952
1 274.28
100
648.86
51.5
625.42
48.5
—
0
202.26
16
491.98
39.1
133.43
9.5
-28.202
-2.2
13.082
1.1
118.31
8.4
24.604
2
109.5
7.9
8.022
13.602
742.47
100
386.28
56
356.19
44
—
0
114.55
15
264.77
31.4
91.424
12.6
-15.395
-2.2
9.752
0.9
85.781
11.3
10.392
1.5
76.545
10.1
6.259
12.249
666.2
100
334.65
49.4
331.55
50.6
—
0
92.533
14.6
247.92
38
83.631
12.6
-13.832
-1.8
14.87
1.6
84.669
12.4
12.773
1.6
71.896
10.7
5.79
12.421
553.95
100
262.19
46.2
291.76
53.8
—
0
78.012
18.4
209.89
38.7
81.869
15.1
-10.568
-2.5
11.651
1.5
82.952
14.1
17.713
2.1
65.239
12.1
5.332
12.236
600.5
100
261.35
42.6
339.15
57.4
—
0
70.417
12.7
243.28
42.4
95.877
15
-3.438
-0.9
5.55
1.5
97.989
15.5
14.258
2.6
83.731
13
6.856
12.213